Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML). The information can help physicians decide whether a more intensive approach is needed. Research led by St. Jude Children’s Research Hospital investigators has identified the best test for measuring that response and guiding therapy. Read more here.
Study mentioned: Inaba H, et al. Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia. J Clin Oncol. 2012 Sep 10. [Epub ahead of print] PMID: 22965955
No comments:
Post a Comment